1 Min Read
May 22 (Reuters) - Taro Pharmaceutical Industries Ltd
* Taro provides results for year ended March 31, 2017
* Q4 sales $196.4 million
* Qtrly earnings per share $2.05 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.